Vaccines against influenza virus
    1.
    发明授权
    Vaccines against influenza virus 失效
    针对流感病毒的疫苗

    公开(公告)号:US08658180B2

    公开(公告)日:2014-02-25

    申请号:US12541804

    申请日:2009-08-14

    摘要: Disclosed are immunogenic conjugates having the general formula: M2e-Cys-S—CH2—C(O)—NH—CH2—CH2-C(O—)NH-Lys-Pr, were M2e is the influenza M2 ectodomain (M2e) peptide; Cys is a cysteine amino acid residue present in the M2e peptide; S the sulfur present in the cysteine amino acid residue; CH2-CO—NH—CH2-CH2-CO the linking group; NH the amine group present in a lysine residue of the carrier; Lys is a lysine amino acid residue and Pr the carrier protein. Also disclosed are isolated immunogens that include an immunogenic fragment of an influenza HA protein including the polybasic cleavage site, wherein the immunogenic fragment of the influenza HA protein has been modified to remove an N-terminal leader amino acid sequence and a C-terminal transmembrane domain. Also disclosed are methods producing an influenza vaccine specific for an identified influenza strain.

    摘要翻译: 公开了具有以下通式的免疫原性缀合物:M2e-Cys-S-CH2-C(O)-NH-CH2-CH2-C(O-NH-Lys-Pr),M2e是流感M2胞外域(M2e)肽 ; Cys是存在于M2e肽中的半胱氨酸氨基酸残基; S存在于半胱氨酸氨基酸残基中的硫; CH2-CO-NH-CH2-CH2-CO连接基团; NH存在于载体的赖氨酸残基中的胺基; Lys是赖氨酸氨基酸残基,Pr是载体蛋白。 还公开了分离的免疫原,其包括包括多碱性切割位点的流感HA蛋白的免疫原性片段,其中已经修饰了流感HA蛋白的免疫原性片段以除去N-末端前导氨基酸序列和C-末端跨膜结构域 。 还公开了产生针对所鉴定的流感病毒株特异的流感疫苗的方法。

    VACCINES AGAINST INFLUENZA VIRUS
    4.
    发明申请
    VACCINES AGAINST INFLUENZA VIRUS 失效
    疫苗对流感病毒

    公开(公告)号:US20100150954A1

    公开(公告)日:2010-06-17

    申请号:US12541804

    申请日:2009-08-14

    摘要: Disclosed are immunogenic conjugates having the general formula: M2e-Cys-S—CH2—C(O)—NH—CH2—CH2-C(O—)NH-Lys-Pr, were M2e is the influenza M2 ectodomain (M2e) peptide; Cys is a cysteine amino acid residue present in the M2e peptide; S the sulfur present in the cysteine amino acid residue; CH2-CO—NH—CH2-CH2-CO the linking group; NH the amine group present in a lysine residue of the carrier; Lys is a lysine amino acid residue and Pr the carrier protein. Also disclosed are isolated immunogens that include an immunogenic fragment of an influenza HA protein including the polybasic cleavage site, wherein the immunogenic fragment of the influenza HA protein has been modified to remove an N-terminal leader amino acid sequence and a C-terminal transmembrane domain. Also disclosed are methods producing an influenza vaccine specific for an identified influenza strain.

    摘要翻译: 公开了具有以下通式的免疫原性缀合物:M2e-Cys-S-CH2-C(O)-NH-CH2-CH2-C(O-NH-Lys-Pr),M2e是流感M2胞外域(M2e)肽 ; Cys是存在于M2e肽中的半胱氨酸氨基酸残基; S存在于半胱氨酸氨基酸残基中的硫; CH2-CO-NH-CH2-CH2-CO连接基团; NH存在于载体的赖氨酸残基中的胺基; Lys是赖氨酸氨基酸残基,Pr是载体蛋白。 还公开了分离的免疫原,其包括包括多碱性切割位点的流感HA蛋白的免疫原性片段,其中已经修饰了流感HA蛋白的免疫原性片段以除去N-末端前导氨基酸序列和C-末端跨膜结构域 。 还公开了产生针对所鉴定的流感病毒株特异的流感疫苗的方法。